Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

The Fusion Landscape of Anaplastic Large Cell Lymphoma: An L.L.M.P.P. Study

Andrew L. Feldman, Guangzhen Hu, Surendra Dasari, Lisa M. Rimsza, David W. Scott, Jimena B. Gimenez, Farah M. Salama, Min Shi, Elías Campo, Wing Chung Chan, James R. Cook, Giorgio Inghirami, Elaine S. Jaffe, Ryan Morin, Phillipp W. Raess, Andreas Rosenwald, Kerry J. Savage, Louis M. Staudt, George W. Wright, Catalina Amador, Jan Delabie, Timothy C. Greiner, Javeed Iqbal, Laura K. Hilton, Sarah L. Ondrejka, German Ott, Stefania Pittaluga, Graham W. Slack, Susan L. Slager, Joo Y. Song, Hao-Wei Wang, Ahmed A. Aljudi, Stephen M. Ansell, Carlos Barrionuevo, James R. Cerhan, Jennifer R. Chapman-Fredricks, Weina Chen, Laurence de Leval, Alejandro A. Gru, David L. Jaye, Liuyan Jiang, Brad S. Kahl, Kennosuke Karube, Young Hyeh Ko, Eric Mou, Matthew J. Maurer, L. Jeffrey Medeiros, Roberto N. Miranda, Naoki Oishi, Perry M. Anamarija, Akira Satou, Xueju Wang, Ryan A. Wilcox, Xiaojun Wu, Tadashi Yoshino, Yu Zeng

Blood (2024) 144 (Supplement 1): 2974.

https://doi.org/10.1182/blood-2024-202410

Published: 2024

Journal Articles

Pathogenesis and Clinical Relevance of Diffuse Large B-Cell Lymphoma Proteogenotypes

Blood (2024) 144 (Supplement 1): 229.

https://doi.org/10.1182/blood-2024-204606

Published: 2024

Journal Articles

Genetic Subclones Reveal Phenotypic Heterogeneity in Diffuse Large B-Cell Lymphoma

Boya Wang, George W. Wright, Julius C. Enssle, Yandan Yang, Da Wei Huang, Xin Yu, Arvin E Ruiz, James D. Phelan, Arthur L Shaffer, III, Thomas Oellerich, Giorgio Inghirami, Louis M. Staudt

Blood (2024) 144 (Supplement 1): 451.

https://doi.org/10.1182/blood-2024-204201

Published: 2024

Journal Articles

Prediction of Early Disease Progression at 24 Months (POD24) Using Pre-Treatment Biopsies from Patients with Follicular Lymphoma (FL) Treated with Immunochemotherapy (IC)

George W. Wright, Colleen A. Ramsower, James R. Cerhan, Anne J. Novak, Brian K. Link, Matthew J. Maurer, Raphael Mwangi, Allison C. Rosenthal, Thomas M. Habermann, Lou Staudt, Robert Kridel, David W. Scott, Christian Steidl, Lisa M. Rimsza

Blood (2022) 140 (Supplement 1): 6426–6427.

https://doi.org/10.1182/blood-2022-160351

Published: 2022

Journal Articles

Phase 2 Study of Acalabrutinib Window Prior to Frontline Therapy in Untreated Aggressive B-Cell Lymphoma: Preliminary Results and Correlatives of Response to Acalabrutinib

Blood (2021) 138 (Supplement 1): 524.

https://doi.org/10.1182/blood-2021-145228

Published: 2021

Journal Articles

Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior

Blood (2021) 138 (17): 1570–1582.

https://doi.org/10.1182/blood.2021012052

Published: 2021

Includes: Supplemental data

Journal Articles

Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma

Bruno M. Grande, Daniela S. Gerhard, Aixiang Jiang, Nicholas B. Griner, Jeremy S. Abramson, Thomas B. Alexander, Hilary Allen, Leona W. Ayers, Jeffrey M. Bethony, Kishor Bhatia, Jay Bowen, Corey Casper, John Kim Choi, Luka Culibrk, Tanja M. Davidsen, Maureen A. Dyer, Julie M. Gastier-Foster, Patee Gesuwan, Timothy C. Greiner, Thomas G. Gross, Benjamin Hanf, Nancy Lee Harris, Yiwen He, John D. Irvin, Elaine S. Jaffe, Steven J. M. Jones, Patrick Kerchan, Nicole Knoetze, Fabio E. Leal, Tara M. Lichtenberg, Yussanne Ma, Jean Paul Martin, Marie-Reine Martin, Sam M. Mbulaiteye, Charles G. Mullighan, Andrew J. Mungall, Constance Namirembe, Karen Novik, Ariela Noy, Martin D. Ogwang, Abraham Omoding, Jackson Orem, Steven J. Reynolds, Christopher K. Rushton, John T. Sandlund, Roland Schmitz, Cynthia Taylor, Wyndham H. Wilson, George W. Wright, Eric Y. Zhao, Marco A. Marra, Ryan D. Morin, Louis M. Staudt

Blood (2019) 133 (12): 1313–1324.

https://doi.org/10.1182/blood-2018-09-871418

Published: 2019

Includes: Supplemental data

Journal Articles

A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome

Blood (2018) 132 (4): 413–422.

https://doi.org/10.1182/blood-2018-03-838136

Published: 2018

Includes: Supplemental data

Journal Articles

Microrna-17~92 Cluster Upregulates NF-KB Activity Via Suppressing Multiple NF-KB Negative Regulators Mediating Ubiquitination

Xianhuo Wang, MD, Huaqing Wang, Chengfeng Bi, Xiaoyan Zhang, Xin Huang, Xuan Zhang, Javeed Iqbal, George W Wright, Louis M Staudt, Wing C Chan, Timothy W McKeithan, Ping Wang, Huilai Zhang, Kai Fu, MD PhD

Blood (2015) 126 (23): 3638.

https://doi.org/10.1182/blood.V126.23.3638.3638

Published: 2015

Journal Articles

Accurate Diagnosis of Aggressive B Cell Non-Hodgkin Lymphomas Using Gene Expression Profiling of Formalin-Fixed, Paraffin-Embedded Tissues

Blood (2014) 124 (21): 3016.

https://doi.org/10.1182/blood.V124.21.3016.3016

Published: 2014

Journal Articles

Genetic and Pharmacologic Notch4 Inhibition Synergizes with FLT3 Tyrosine Kinase Inhibition in Vitro to More Effectively Eliminate FLT3/ITD-Positive Leukemia Cells

Courtney M. Shirley, PhD, S. Haihua Chu, PhD, Yandan Yang, PhD, George W. Wright, PhD, Louis M. Staudt, MD PhD, Donald Small, MD PhD

Blood (2014) 124 (21): 3583.

https://doi.org/10.1182/blood.V124.21.3583.3583

Published: 2014

Journal Articles

A Phase 2/3 Multicenter, Randomized Study Comparing the Efficacy and Safety of Lenalidomide Versus Investigator’s Choice in Relapsed/Refractory DLBCL

Myron S. Czuczman, MD, Andrew Davies, BM PhD, Kim M Linton, MBChB, MRCP, PhD, Nina Wagner-Johnston, Randy D. Gascoyne, MD, David A. Eberhard, MD PhD, Gilles Salles, MDPhD, Thomas E. Witzig, MD, Pier Luigi Zinzani, MD, PhD, George W. Wright, PhD, Louis M. Staudt, MD PhD, Jacqueline Repici, Dale Song, Oliver Manzke, MD, Ian D Lewis, MBBS, PhD

Blood (2014) 124 (21): 628.

https://doi.org/10.1182/blood.V124.21.628.628

Published: 2014

Journal Articles

Cell-of-Origin Assignment in Diffuse Large B-Cell Lymphoma Determined By Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Has Prognostic Significance Independent of IPI and MYC/BCL2 Immunohistochemistry

David W. Scott, MBChB, PhD, Anja Mottok, MD, Daisuke Ennishi, MD PhD, George W. Wright, PhD, Pedro Farinha, MD, Susana Ben-Neriah, MSc, Robert Kridel, MD MPH, Garrett S Barry, B.Sc, Christoffer E Hother, MDPhD, Kerry J. Savage, MDMSc, Laurie H. Sehn, MDMPH, Louis M. Staudt, Joseph M. Connors, MD, Lisa M. Rimsza, MD, Randy D. Gascoyne, MD

Blood (2014) 124 (21): 1624.

https://doi.org/10.1182/blood.V124.21.1624.1624

Published: 2014

Journal Articles

Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma

Blood (2014) 123 (11): 1681–1690.

https://doi.org/10.1182/blood-2013-05-500595

Published: 2014

Includes: Supplemental data

Journal Articles

Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue

Blood (2014) 123 (8): 1214–1217.

https://doi.org/10.1182/blood-2013-11-536433

Published: 2014

Includes: Supplemental data

Journal Articles

Determining Cell-Of-Origin Subtypes In Diffuse Large B-Cell Lymphoma Using Gene Expression Profiling On Formalin-Fixed Paraffin-Embedded Tissue – An L.L.M.P.P. Project

Blood (2013) 122 (21): 73.

https://doi.org/10.1182/blood.V122.21.73.73

Published: 2013

Journal Articles

Genetic Abnormalities in Follicular Lymphoma and Transformed Follicular Lymphoma.

Blood (2012) 120 (21): 2648.

https://doi.org/10.1182/blood.V120.21.2648.2648

Published: 2012

Journal Articles

Gene Expression Signatures That Delineate Biologic and Prognostic Subgroups in Peripheral T-Cell Lymphoma

Blood (2012) 120 (21): 679.

https://doi.org/10.1182/blood.V120.21.679.679

Published: 2012

Journal Articles

Recurrent Oncogenic Mutations in CCND3 in Aggressive Lymphomas

Roland Schmitz, PhD, Sameer Jhavar, MD, Wenming Xiao, PhD, Xuelu Liu, John Powell, George W. Wright, Wing C. Chan, MD, Elaine S. Jaffe, MD, Randy D. Gascoyne, MD, Elias Campo, MD, Andreas Rosenwald, MD, German Ott, MD, Jan Delabie, MD, PhD, Lisa M. Rimsza, MD, Louis M. Staudt, MD, PhD

Blood (2011) 118 (21): 435.

https://doi.org/10.1182/blood.V118.21.435.435

Published: 2011

Journal Articles

Rituximab Is Associated with Prolonged Immunoglobulin Deficiency In Newly Diagnosed Patients with Aggressive B-Cell Lymphoma Receiving Immunochemotherapy

Kieron Dunleavy, MD, Benjamin L.W. Reiter, Cliona M. Grant, MD, Margaret Shovlin, RN, George W. Wright, Thomas A. Fleisher, MD, Wyndham H. Wilson, MD, PhD

Blood (2010) 116 (21): 2881.

https://doi.org/10.1182/blood.V116.21.2881.2881

Published: 2010

NARROW

The Fusion Landscape of Anaplastic Large Cell Lymphoma: An L.L.M.P.P. Study

Pathogenesis and Clinical Relevance of Diffuse Large B-Cell Lymphoma Proteogenotypes

Genetic Subclones Reveal Phenotypic Heterogeneity in Diffuse Large B-Cell Lymphoma

Prediction of Early Disease Progression at 24 Months (POD24) Using Pre-Treatment Biopsies from Patients with Follicular Lymphoma (FL) Treated with Immunochemotherapy (IC)

Phase 2 Study of Acalabrutinib Window Prior to Frontline Therapy in Untreated Aggressive B-Cell Lymphoma: Preliminary Results and Correlatives of Response to Acalabrutinib

Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior

Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma

A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome

Microrna-17~92 Cluster Upregulates NF-KB Activity Via Suppressing Multiple NF-KB Negative Regulators Mediating Ubiquitination

Accurate Diagnosis of Aggressive B Cell Non-Hodgkin Lymphomas Using Gene Expression Profiling of Formalin-Fixed, Paraffin-Embedded Tissues

Genetic and Pharmacologic Notch4 Inhibition Synergizes with FLT3 Tyrosine Kinase Inhibition in Vitro to More Effectively Eliminate FLT3/ITD-Positive Leukemia Cells

A Phase 2/3 Multicenter, Randomized Study Comparing the Efficacy and Safety of Lenalidomide Versus Investigator’s Choice in Relapsed/Refractory DLBCL

Cell-of-Origin Assignment in Diffuse Large B-Cell Lymphoma Determined By Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Has Prognostic Significance Independent of IPI and MYC/BCL2 Immunohistochemistry

Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma

Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue

Determining Cell-Of-Origin Subtypes In Diffuse Large B-Cell Lymphoma Using Gene Expression Profiling On Formalin-Fixed Paraffin-Embedded Tissue – An L.L.M.P.P. Project

Genetic Abnormalities in Follicular Lymphoma and Transformed Follicular Lymphoma.

Gene Expression Signatures That Delineate Biologic and Prognostic Subgroups in Peripheral T-Cell Lymphoma

Recurrent Oncogenic Mutations in CCND3 in Aggressive Lymphomas

Rituximab Is Associated with Prolonged Immunoglobulin Deficiency In Newly Diagnosed Patients with Aggressive B-Cell Lymphoma Receiving Immunochemotherapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only